ATYR
aTyr Pharma
ATYR
ATYR
47 hedge funds and large institutions have $154M invested in aTyr Pharma in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
11% less capital invested
Capital invested by funds: $172M → $154M (-$18.6M)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
47
Holding in Top 10
1
Calls
$656K
Puts
$703K
Top Buyers
| 1 | +$9.16M | |
| 2 | +$1.55M | |
| 3 | +$1.54M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$859K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$787K |
Top Sellers
| 1 | -$3.94M | |
| 2 | -$3.09M | |
| 3 | -$1.3M | |
| 4 |
Jane Street
New York
|
-$1.24M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$743K |